On December 31, 2025, Owens & Minor completed the sale of its Products & Healthcare Services business, including the Owens & Minor brand, to Platinum Equity for $375 million in cash, subject to customary adjustments, and retained a 5% equity stake, thereby finalizing its transformation into Accendra Health, a pure-play home-based care company. In connection with the closing, the company put in place an amended and restated receivables sale program of up to $150 million that will be accounted for as true sales under ASC 860, adjusted its capital structure via releases under certain credit facilities and indentures, exited its P&HS executive leadership roles while consolidating accounting responsibilities under CFO Jonathan Leon, amended its executive deferred compensation plan for departing P&HS participants, and filed corporate amendments to change its legal name to Accendra Health, Inc., with NYSE trading under the new name and ticker “ACH” expected to begin on January 2, 2026.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.